Early Detection Of Prostate Cancer An Issue Of Urologic Clinics
Download Early Detection Of Prostate Cancer An Issue Of Urologic Clinics full books in PDF, epub, and Kindle. Read online free Early Detection Of Prostate Cancer An Issue Of Urologic Clinics ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: Stacy Loeb |
Publisher |
: Elsevier Health Sciences |
Total Pages |
: 145 |
Release |
: 2014-05-28 |
ISBN-10 |
: 9780323297264 |
ISBN-13 |
: 0323297269 |
Rating |
: 4/5 (64 Downloads) |
Synopsis Early Detection of Prostate Cancer, An Issue of Urologic Clinics by : Stacy Loeb
PSA screening remains highly controversial due to several important disadvantages. More PSA is produced with prostatic enlargement and in other benign conditions such as urinary tract infections. False positive tests can then lead to unnecessary diagnostic workup with invasive prostate biopsy. Another major problem with screening programs in general is overdiagnosis of cancers that would not have caused harm during the patient's lifetime. For example, many prostate cancers have a relatively indolent behavior so may not require diagnosis or treatment in a patient with limited life expectancy. All forms of prostate cancer treatment have potential urinary and sexual side effects, so reducing overdiagnosis and overtreatment are critical public health issues. Because screening has many proven benefits but also significant harms, there are widely disparate guidelines on prostate cancer screening from major organizations worldwide. This issue of the Urologic Clinics will provide insights into the many different prostate cancer guidelines and related policy issues.
Author |
: Stacy Loeb |
Publisher |
: Clinics: Internal Medicine |
Total Pages |
: 0 |
Release |
: 2014-04-25 |
ISBN-10 |
: 0323297250 |
ISBN-13 |
: 9780323297257 |
Rating |
: 4/5 (50 Downloads) |
Synopsis Early Detection of Prostate Cancer, an Issue of Urologic Clinics by : Stacy Loeb
PSA screening remains highly controversial due to several important disadvantages. More PSA is produced with prostatic enlargement and in other benign conditions such as urinary tract infections. False positive tests can then lead to unnecessary diagnostic workup with invasive prostate biopsy. Another major problem with screening programs in general is overdiagnosis of cancers that would not have caused harm during the patient's lifetime. For example, many prostate cancers have a relatively indolent behavior so may not require diagnosis or treatment in a patient with limited life expectancy. All forms of prostate cancer treatment have potential urinary and sexual side effects, so reducing overdiagnosis and overtreatment are critical public health issues. Because screening has many proven benefits but also significant harms, there are widely disparate guidelines on prostate cancer screening from major organizations worldwide. This issue of the Urologic Clinics will provide insights into the many different prostate cancer guidelines and related policy issues.
Author |
: Marc A. Bjurlin |
Publisher |
: Elsevier Health Sciences |
Total Pages |
: |
Release |
: 2017-11-06 |
ISBN-10 |
: 9780323549066 |
ISBN-13 |
: 0323549063 |
Rating |
: 4/5 (66 Downloads) |
Synopsis Prostate Cancer, An Issue of Urologic Clinics, E-Book by : Marc A. Bjurlin
Dr. Samir Taneja, Consulting Editor, is stepping into the Guest Editor role for this issue of Urologic Clinics devoted to Prostate Cancer. He has assembled top experts to address the latest advances in the diagnosis and treatment of prostate cancer. Articles are devoted to the following topics: Whom to Biopsy: Pre-Diagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators; How to Biopsy: Transperineal vs. Tranrectal, Saturation vs. Targeted: What’s the Evidence; Pre-Diagnostic Risk and Assessment with Imaging and Image-guided Biopsy; Whom to treat: Post-Diagnostic Risk Assessment with Gleason score, Risk Models, and Genomic Classifier; Strategies for Staging and Utilization of Imaging; Contemporary Active Surveillance: Candidate Selection, Follow-up Tools, and Expected Outcomes; Focal Ablation of Early Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome; Extent of Lymphadenectomy at Time of Prostatectomy: An Evidence-based Approach; How to Radiate the Prostate: Hypofractionation, Sterotactic Body Radiation Therapy, and Conventional Intensity-Modulated Radiotherapy; Managing Relapse after Surgical Therapy: Adjuvant vs. Salvage Therapy; Newly diagnosed Metastatic Prostate Cancer – Has the Paradigm Changed; Role of Local therapy in Oligometastatic Prostate Cancer: Should we Expect Cure; Approaching the High-Risk Patient; and Castration-Resistant Prostate Cancer: An Algorithmic Approach. Readers will come away with state-of-the-art information on strategies for diagnosing, treating, and managing prostate cancer.
Author |
: DIANE Publishing Company |
Publisher |
: DIANE Publishing |
Total Pages |
: 141 |
Release |
: 1998 |
ISBN-10 |
: 9780788132902 |
ISBN-13 |
: 0788132903 |
Rating |
: 4/5 (02 Downloads) |
Synopsis Costs and Effectiveness of Prostate Cancer Screening in Elderly Men by : DIANE Publishing Company
Author |
: Joseph A. Smith |
Publisher |
: |
Total Pages |
: 16 |
Release |
: 1990 |
ISBN-10 |
: OCLC:165524847 |
ISBN-13 |
: |
Rating |
: 4/5 (47 Downloads) |
Synopsis Early detection and treatment of localized carcinoma of the prostate by : Joseph A. Smith
Author |
: Donna Pauler Ankerst |
Publisher |
: Springer Science & Business Media |
Total Pages |
: 391 |
Release |
: 2009-01-24 |
ISBN-10 |
: 9781603272810 |
ISBN-13 |
: 160327281X |
Rating |
: 4/5 (10 Downloads) |
Synopsis Prostate Cancer Screening by : Donna Pauler Ankerst
More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
Author |
: Christopher Sweeney |
Publisher |
: Elsevier Health Sciences |
Total Pages |
: 225 |
Release |
: 2013-12-28 |
ISBN-10 |
: 9780323227230 |
ISBN-13 |
: 0323227236 |
Rating |
: 4/5 (30 Downloads) |
Synopsis Prostate Cancer, An Issue of Hematology/Oncology Clinics of North America by : Christopher Sweeney
This issue of Hematology/Oncology Clinics is focused on Prostate Cancer and highlights topics such as: Prevention, Early Detection, Biomarkers, Risk stratification, Imaging in Prostate Cancer, Adjuvant hormonal therapy, Management of patient with biochemical relapse, Management of patient with newly metastatic disease, and Bone Health Management.
Author |
: Leonard G. Gomella |
Publisher |
: Elsevier |
Total Pages |
: 240 |
Release |
: 2021-08-28 |
ISBN-10 |
: 0323791670 |
ISBN-13 |
: 9780323791670 |
Rating |
: 4/5 (70 Downloads) |
Synopsis Prostate Cancer Genetics: Changing the Paradigm of Care, An Issue of Urologic Clinics by : Leonard G. Gomella
In this issue of Urologic Clinics, guest editors Leonard G. Gomella and Veda Giri bring their considerable expertise to the topic of Prostate Cancer Genetics: Changing the Paradigm of Care. Provides in-depth, clinical reviews on Prostate Cancer Genetics, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Author |
: Thomas J. Polascik |
Publisher |
: Springer |
Total Pages |
: 475 |
Release |
: 2017-02-22 |
ISBN-10 |
: 9783319499116 |
ISBN-13 |
: 3319499114 |
Rating |
: 4/5 (16 Downloads) |
Synopsis Imaging and Focal Therapy of Early Prostate Cancer by : Thomas J. Polascik
This text encompass an up-to-date, comprehensive review of the state-of-the-art for gland preserving therapies. Fully updated and revised, this text evaluates the scientific evidence for the evolving trend to treat intermediate risk, clinically localized prostate cancer in a focally ablative manner with novel gland-preserving, focal therapy methods. Various ablative devices such as high intensity focused ultrasound, irreversible electroporation, photodynamic therapy, cryotherapy and laser ablation, among others, is discussed in regard to their strengths and limitations as a therapeutic modality. Emphasis is placed on patient selection and outcomes utilizing both advanced imaging techniques and pathologic evaluation. Current and new approaches to image cancer foci within the prostate (multiparametric ultrasonography, multiparametric magnetic resonance image, etc) are presented along with various biopsy techniques, including robotics to map prostate cancer. Patient selection based on imaging and genomic classification, adjuvants to enhance therapy, treatment strategy, outcomes and patient centered concerns is discussed, providing an acceptable balance between cancer control and improved quality of life for patients. Written by experts in the field and lavishly illustrated with detailed line-art and photographs, Imaging and Focal Therapy of Early Prostate Cancer, Second Edition is designed as a comprehensive resource for urologists, radiation oncologists, medical oncologists, radiologists, uropathologists, molecular biologists, biomedical engineers, other clinicians –- residents, fellows, nurses and allied professionals -- and researchers with an interest in the diagnosis and novel treatment of prostate cancer. It will provide insight into the latest research and clinical applications of image-guided diagnosis and minimally invasive focal, gland-preserving treatment for prostate cancer.
Author |
: Eric A. Klein |
Publisher |
: Springer Science & Business Media |
Total Pages |
: 735 |
Release |
: 2004-05-07 |
ISBN-10 |
: 9781592597765 |
ISBN-13 |
: 1592597769 |
Rating |
: 4/5 (65 Downloads) |
Synopsis Management of Prostate Cancer by : Eric A. Klein
Although much progress has been made in the four years since the first edition of Management of Prostate Cancer, prostate cancer remains a significant biological, me- cal, and personal challenge for millions of men. In this interval, some important trends and observations have emerged that represent real progress in the field and which will shape the direction of clinical practice and research in the next 5–10 years. These obs- vations include: (1) a decline in prostate-related cancer mortality in the United States, likely owing to a combination of factors including screening, more aggressive and earlier therapy, and improvements in specific therapies; (2) a significant downward pathological stage migration, so that an individual’s chance of cure for a given stage, grade, and PSA is better now than it was early in the PSA era, even without associated improvements in individual therapies; (3) the recognition of new PSA isoforms that may refine screening strategies; (4) several randomized, phase III clinical trials demonstrating survival adv- tages of one form of therapy over another in selected populations (external beam rad- therapy with adjuvant hormones vs radiotherapy alone, radical prostatectomy vs observation); (5) a focus on the biology of bone and bone metastasis, and new agents that reduce skeletal-related events and which may inhibit the growth of new metastases; (6) second-generation anti-PSMA antibodies with improved potential for imaging and therapy; (7) the development and widespread adoption of nomograms that assist in cli- cal decision-making for individual patients; (8) the identification of new genes that